News for PainReform Ltd. (PRFX)

PainReform (PRFX) has made a significant strategic move by investing in LayerBio, a private biotech firm in Boston, to enhance its portfolio in ophthalmology. T

This Investment will add a differentiated ophthalmic platform, targeting an estimated 3 million annual U.S. cataract surgeries with long-acting, ”œdropless”

PainReform Ltd. (PRFX) announces a strategic investment in LayerBio Inc., with a milestone-based funding structure of up to $3 million. LayerBio's OcuRi

Shares of AppLovin Corporation APP rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results. ...

**media[618133]**

PainReform Ltd. (PRFX) has announced a strategic acquisition of DeepSolar to bolster its portfolio with AI-driven solar analytics. Wall Street analysts

**media[588464]**

**media[558305]**

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling around 100 points on Tuesday. The Dow traded down 0.38% to 44,378.28 whil...

U.S. stocks traded mixed this morning, with the Dow Jones index falling around 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down...

PainReform Ltd. (PRFX), Tuesday announced of the business activity of DeepSolar, an AI-driven solar analytics platform owned by BladeRanger Ltd. The financial terms of the deal have not been disclosed.

DeepSolar brings new customer base in creation, including major utility-scalesolar operators and independent power producers, whilebreaking into the residential

Cumberland Pharmaceuticals (CPIX) experienced a significant stock movement, with its share price dropping by 5.02% to $2.46. The trading volume reached 12,902 s

Amarin Corporation (AMRN) experienced a significant stock movement with a sharp decline of 5.55%. The stock is currently trading at $0.592 per share with a trad

Massachusetts-based Allurion Technologies Inc. (ALUR) is up over 297 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

Ironwood Pharmaceuticals (IRWD) recently experienced a significant stock price drop of 5.20%, bringing its share price to $3.58. The trading volume reached 431,

Ironwood Pharmaceuticals (IRWD) experienced a notable stock price increase of 5.20%. The stock is currently trading at $4.56 per share with a trading volume of

Ironwood Pharmaceuticals (IRWD) experienced a significant stock price decline of 5.30%, trading at $4.20 per share. The trading volume reached 885,652 shares wi

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.77%